Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study
- PMID: 22584044
- PMCID: PMC3391973
- DOI: 10.1186/1471-2466-12-19
Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study
Abstract
Background: Diagnostic and treatment approaches for sarcoidosis have changed dramatically over the past decade. Yet, the most recent reports of trends in hospitalizations of sarcoidosis patients are over ten years old. The objectives of this study were to determine the incidence of sarcoidosis among hospitalized patients and to analyze recent trends and seasonality of hospitalizations in sarcoidosis patients.
Methods: We performed a retrospective cohort study of the Nationwide Inpatient Sample from 1998 through 2008. We identified all hospitalizations with a primary or secondary diagnosis of sarcoidosis (ICD-9-CM code 135). Incidence was modeled as a seasonal time series about a linear trend.
Results: Time series analysis of the monthly number of hospitalizations revealed a distinct positive linear trend. Over the study period, the number of hospitalized patients with sarcoidosis increased from 37,516 to 70,947 cases. Trends were most pronounced in patients older than 55 years (p < 0.0001), African Americans (p < 0.0001), females (p = 0.0289), and non-Medicaid populations (p < 0.0001). Hospitalizations are seasonal with highest incidence in January through March.
Conclusions: Hospitalizations among sarcoidosis patients have almost doubled during the past decade, with disproportionate rate increases in African Americans, women, and older patients. The rate also increases among patients with insurance other than Medicaid. This study indicates the need for heightened surveillance of sarcoidosis patients given the unknown consequences of evolving treatment approaches. Our results point to a need for research investigating risk factors for hospitalization, including medications, co-morbidities, demographics, and socioeconomic status.
Figures
Similar articles
-
Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States.J Am Heart Assoc. 2018 Jan 22;7(2):e007844. doi: 10.1161/JAHA.117.007844. J Am Heart Assoc. 2018. PMID: 29358190 Free PMC article.
-
Hospitalization for patients with sarcoidosis: 1979-2000.Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):124-9. Sarcoidosis Vasc Diffuse Lung Dis. 2006. PMID: 17937108
-
National Temporal Trends in Hospitalization and Inpatient Mortality in Patients With Pulmonary Sarcoidosis in the United States Between 2007 and 2018.Chest. 2022 Jan;161(1):152-168. doi: 10.1016/j.chest.2021.07.2166. Epub 2021 Aug 5. Chest. 2022. PMID: 34364869
-
Morbidity and mortality in sarcoidosis.Curr Opin Pulm Med. 2014 Sep;20(5):472-8. doi: 10.1097/MCP.0000000000000080. Curr Opin Pulm Med. 2014. PMID: 25029298 Free PMC article. Review.
-
Disease Burden and Variability in Sarcoidosis.Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT. Ann Am Thorac Soc. 2017. PMID: 29087725 Free PMC article. Review.
Cited by
-
Association of Area Deprivation Index with Adherence to Proposed Regimen in Patients with Sarcoidosis in Detroit, Michigan.Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024031. doi: 10.36141/svdld.v41i2.15587. Sarcoidosis Vasc Diffuse Lung Dis. 2024. PMID: 38940707 Free PMC article.
-
Impact of comorbid heart failure among hospitalized patients with sarcoidosis: A United States population-based cohort study.Int J Cardiol Heart Vasc. 2023 Sep 29;49:101275. doi: 10.1016/j.ijcha.2023.101275. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 37822667 Free PMC article.
-
Sarcoidosis lung transplantation waitlist mortality, a national registry database study.ERJ Open Res. 2023 Jul 17;9(4):00738-2022. doi: 10.1183/23120541.00738-2022. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37465560 Free PMC article.
-
Sex Differences in Temporal Trends in Hospitalizations and In-Hospital Mortality in Patients with Sarcoidosis in Spain from 2001 to 2020.J Clin Med. 2022 Sep 13;11(18):5367. doi: 10.3390/jcm11185367. J Clin Med. 2022. PMID: 36143020 Free PMC article.
-
Elderly Onset Sarcoidosis: A Case Report.Cureus. 2021 Dec 15;13(12):e20443. doi: 10.7759/cureus.20443. eCollection 2021 Dec. Cureus. 2021. PMID: 35047280 Free PMC article.
References
-
- Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–755. - PubMed
-
- Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–1889. - PubMed
-
- Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975–2001. Chest. 2004;126:1431–1438. doi: 10.1378/chest.126.5.1431. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
